SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Haugland who wrote (205)5/10/1998 12:03:00 PM
From: Richard Haugland  Read Replies (1) of 3044
 
MLNM downgrades. Analysts now show 6 "strong buy" and 2 "buy" versus a perfect "strong buy" rating two months ago.

biz.yahoo.com

Some upward revision of earnings estimates for the current quarter (less loss) and downward for the subsequent quarter.

Seems more like a response to the stock's price drop than a prediction of reality. MLNM handily beat the analysts' number last quarter.

I also noted that Sangstat, which also used to have a perfect "strong buy" recommendation in Zacks now has some (or one) simple "buy" recommendation.

I had hoped that the Entremed enthusiasm of this past week would invigorate development-stage pharma companies but I have not seen much positive effect.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext